The Genetic and Cellular Basis of Regulation of the Immune Response to Tumor Antigens

  • Mark Irwin Greene
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 11)


Immunity in the mammalian host has evolved as an integrated network of interacting cells and cell products that coordinately recognize and respond to foreign antigenic stimuli. The quality of this response is dictated by the nature of this antigen, as well as by the diverse biologic, immunologic, and genetic constitution of the immunized host. Specificity is accomplished through the expression of clonally distributed receptor structures on the differentiated lymphocyte, which serve to select only those cells that are precommitted to any particular antigenic configuration. The expression of immune responsiveness depends upon the antigen- or receptor-stimulated activation (Jerne, 1975) of such specifically selected cells, by means which are only recently being investigated at the molecular level (Seidman et al., 1979; Sakano et al., 1979).


Major Histocompatibility Complex Spleen Cell Tumor Antigen Suppressor Cell M315 Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abbas, A., Perry, L. L., Bach, B. A., and Greene, M. I., 1980, Idiotype-specific T cell immunity. I. Generation of effector and suppressor T lymphocytes, J. Immunol. 124: 1160.PubMedGoogle Scholar
  2. Aoki, T., Boyse, E. A., and Old, L. J., 1966, Occurrence of natural antibody to the G (Gross) leukemia antigen in mice, Cancer Res. 26: 1415.PubMedGoogle Scholar
  3. Asherson, G. L., and Zembala, M., 1976, Suppressor T-cells in cell mediated immunity, Br. Med. Bull. 32 (2): 158.PubMedGoogle Scholar
  4. Bach, B. A., Sherman, L., Benacerraf, B., and Greene, M. I., 1978, Mechanisms of regulation of cell mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells, J. Immunol. 121: 1460.PubMedGoogle Scholar
  5. Benacerraf, B., and McDevitt, H. O., 1972, Histocompatibility linked immune response genes, Science 175: 273.PubMedCrossRefGoogle Scholar
  6. Bevan, M. J., 1975, Interaction antigens detected by cytotoxic T cells: The major histocompatibility complex as modifier, Nature (London) 256: 419.CrossRefGoogle Scholar
  7. Broder, S., and Waldmann, T. A., 1978, The suppressor cell network in cancer, New Eng. J. Med. 199: 1335.CrossRefGoogle Scholar
  8. Burton, R. C., Chism, S. E., and Warner, N. L., 1977, In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens, J. Immunol. 118: 971.PubMedGoogle Scholar
  9. Callahan, G. N., Allison, J. P., Peligrano, M. A., and Reisfeld, R. A., 1979, Physical association of histocompatibility antigens and tumor associated antigens on the surface of murine lymphoma cells, J. Immunol. 122: 70.PubMedGoogle Scholar
  10. Cantor, H., Shen, F. W., and Boyse, E. A., 1976, Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: After immunization, antigen specific suppressor and helper activities are mediated by distinct T- cell subclasses, J. Exp. Med. 143: 1391.PubMedCrossRefGoogle Scholar
  11. Chesbro, B., Wehrly, K., and Stimpfling, 1974, Host genetic control of recovery from Freund leukemia virus-induced splenomegaly. Mapping of a gene within the major histocompatibility complex, J. Exp. Med. 140: 1457.CrossRefGoogle Scholar
  12. Daynes, R. A., and Spellman, C. W., 1977, Evidence for the generation of suppressor cells by ultraviolet radiation, Cell. Immunol. 31: 182.PubMedCrossRefGoogle Scholar
  13. Doherty, P. C., and Zinkernagel, R. M., 1975, H-2 compatibility is required for T-cellmediated lysis of target cells infected with lymphocytic choriomeningitis virus, J. Exp. Med. 141: 502.PubMedCrossRefGoogle Scholar
  14. Eccles, A., and Alexander, P., 1974, Macrophage content of tumors in relation to metastatic spread and host immune reaction, Nature (London) 250: 667.CrossRefGoogle Scholar
  15. Edelman, G. M., 1976, Surface modulation in cell recognition and cell growth, Science 192: 218.PubMedCrossRefGoogle Scholar
  16. Eggers, A. E., and Wunderlich, J. R., 1975, Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens, J. Immunol. 114: 1554.PubMedGoogle Scholar
  17. Evans, R., and Alexander, P., 1970, Cooperation of immune lymphoid cells with macrophages in tumor immunity, Nature (London) 228: 620.CrossRefGoogle Scholar
  18. Finberg, R., Burakoff, S. J., Cantor, H., and Benacerraf, B., 1978, Biological significance of alloreactivity: T cells stimulated by Sendai virus-coated syngeneic cells specifically lyse allogeneic target cells, Proc. Natl. Acad. Sci. U.S.A. 75: 5145.PubMedCrossRefGoogle Scholar
  19. Finberg, R., Greene, M. I., Benacerraf, B., and Burakoff, S. J., 1979, The cytolytic T lymphocyte response to trinitrophenyl modified syngeneic cells. I. Evidence for antigen specific helper T cells, J. Immunol. 123: 1205.PubMedGoogle Scholar
  20. Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13: 835.PubMedGoogle Scholar
  21. Forbes, J. T., Nakao, Y., and Smith, R. T., 1975, Tumor-specific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens, J. Exp. Med. 141: 1181.CrossRefGoogle Scholar
  22. Fujimoto, S., Chen, C. H., Sabbadini, E., and Sehon, A. H., 1973, Association of tumor and histocompatibility antigens in sera of lymphoma bearing mice, J. Immunol 111: 903.Google Scholar
  23. Fujimoto, S., Greene, M. I., and Sehon, A. H., 1975, Immunosupressor T cells and their factors in tumor bearing hosts, in: Suppressor Cells in Immunity (S. K. Singhal and N. R. St. C. Sinclair, eds.), University of Western Ontario Press, London.Google Scholar
  24. Fujimoto, S., Greene, M. I., and Sehon, A. H., 1976a, Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor bearing hosts, J. Immunol. 116: 791.PubMedGoogle Scholar
  25. Fujimoto, S., Greene, M. I., and Sehon, A. H., 1976b, Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor bearing hosts, J. Immunol. 116: 800PubMedGoogle Scholar
  26. Fujimoto, S., Matsuzawa, T., Nakagawa, K., and Tada, T., 1978 Cellular interactions between cytotoxic and suppressor T cells against syngeneic tumors in the mouse, Cell. Immunol. 38: 378.PubMedCrossRefGoogle Scholar
  27. Germain, R. N., Dorf, M. E., and Benacerraf, B., 1975, Inhibition of T-lymphocyte-mediated tumor specific lysis by alloantisera directed against the H-2 serological specificities of the tumor, J. Exp. Med. 142: 1023.PubMedCrossRefGoogle Scholar
  28. Germain, R. N., Theze, J., Kapp, J., and Benacerraf, B., 1978, Antigen specific T cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen, J. Exp. Med. 147: 123.PubMedCrossRefGoogle Scholar
  29. Gershon, R. K., and Kondo, K., 1969, Mechanism by which the spleen may act in regulating tumor immunity after tumor resection, J. Natl. Cancer Inst. 43 (3): 545.PubMedGoogle Scholar
  30. Gershon, R. K., and Kondo, K., 1971, Infectious immunological tolerance, Immunology 21: 903.PubMedGoogle Scholar
  31. Gershon, R. K., Bernbaum, J. M., Bernbaum, M., and Mitchell, M. S., 1974, Activation of suppressor T cells by tumor cells and specific antibody, Nature (London) 250: 594.CrossRefGoogle Scholar
  32. Glaser, M., and Law, L., 1978, T-T cell collaboration in rejection of a syngeneic SV-40 induced carcinoma in mice, Nature (London) 273: 385.CrossRefGoogle Scholar
  33. Goodwin, J. S., Messner, R. P., Bankhurst, A. D., Peak, G. T., Saiki, J. H., and Williams, R. C., 1977, Prostaglandin-producing suppressor cells in Hodgkins’ disease, New Eng. J. Med. 297 (18): 963.PubMedCrossRefGoogle Scholar
  34. Gorczynski, R. M., 1974, Evidence for in vivo protection against murine-sarcoma virus induced tumors by T lymphocytes from immune animals, J. Immunol. 112 (2): 532.Google Scholar
  35. Greenberg, A. H., and Greene, M., 1976, Non-adaptive rejection of small tumor inocula as a model of immune surveillance, Nature (London) 264: 356.CrossRefGoogle Scholar
  36. Greene, M., and Fujimoto, S., 1974, Immunosuppressor T cells and their factors in tumor bearing hosts, Can. Fed. Proc. 17: 353.Google Scholar
  37. Greene, M. I., and Perry, L. L., 1978, Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells, J. Immunol 121: 2363.PubMedGoogle Scholar
  38. Greene, M. L, and Perry, L. L., 1980, The relationship of alloreactivity to syngeneic tumor immunity, Transplant. Proc. XII: 80.Google Scholar
  39. Greene, M. I., Dorf, M. E., Pierres, A., and Benacerraf, B., 1977a, Reduction of syngeneic tumor growth by an anti-I-J alloantiserum, Proc. Natl. Acad. Sci. U.S.A. 74: 5118.PubMedCrossRefGoogle Scholar
  40. Greene, M. I., Fujimoto, S., and Sehon, A. H., 1977b, Regulation of the immune response to tumor antigens. III. Characterization of thymus suppressor factor(s) produced by tumor bearing hosts, J. Immunol. 119 (2): 757.PubMedGoogle Scholar
  41. Greene, M. I., Perry, L. L., and Benacerraf, B., 1979a, The mechanism and genetic basis of the immune response to tumor antigen, in: Regulation of the Immune Response ( G. Kiburn, J. G. Levy, and H.S. Teh, eds.), pp. 114–130, University of British Columbia Press, Vancouver.Google Scholar
  42. Greene, M. I., Perry, L. L., and Benacerraf, B., 1979b, Regulation of the immune response to tumor antigen. V. Modulation of suppressor T cell activity in vivo, Am. J. Pathol. 95: 159.PubMedGoogle Scholar
  43. Greene, M. L, Sy, M. S., Kripke, M., and Benacerraf, B., 1979c, Impairment of antigen- presenting cell function by ultraviolet radiation, Proc. Natl. Acad. Sci. U.S.A. 76: 6591.PubMedCrossRefGoogle Scholar
  44. Greene, M. I.,Sy, M. S., Nisonoff, A., and Benacerraf, B., 1980, The genetic and cellular basis of antigen and receptor stimulated regulation, Mol. Immunol. (in press).Google Scholar
  45. Haller, O., Hansson, M., Kiessling, R., and Wigzell, H., 1977, Role of nonconventional natural killer cells in resistance against syngeneic tumor cells in vivo, Nature (London) 270: 609.CrossRefGoogle Scholar
  46. Haywood, G. R., and McKhann, C. F., 1971, Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity, J. Exp. Med. 133: 1171.PubMedCrossRefGoogle Scholar
  47. Herberman, R. B., and Holden, H. T., 1978, Natural cell mediated immunity, Adv. Cancer Res. 27: 305.PubMedCrossRefGoogle Scholar
  48. Hibbs, J. B., Lambert, L. H., and Remington, J. S., 1972, Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance, Nature (London) New Biology 235: 48.Google Scholar
  49. Holden, H. T., and Herberman, R. B., 1977, Cytotoxicity against tumor-associated antigens not H-2 restricted, Nature (London) 268: 250.CrossRefGoogle Scholar
  50. Huber, B., Cantor, H., Shen, F. W., and Boyse, E. A., 1976, Independent differentiative pathways of Ly 1 and Ly 23 subclasses of T cells. Experimental production of mice deprived of selected T- cell subclasses, J. Exp. Med. 144: 1128.PubMedCrossRefGoogle Scholar
  51. Invernizzi, G., and Parmiani, G., 1975, Tumour-associated transplantation antigens of chemically induced sarcomata cross-reacting with allogeneic histocompatibility antigens, Nature (London) 254: 713.CrossRefGoogle Scholar
  52. Ishizaka, K., and Adachi, T., 1976, Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses, J. Immunol. 117: 40.PubMedGoogle Scholar
  53. Jerne, N. K., 1975, The immune system: A web of V domains, Ann. Immunol. (Inst. Pasteur) 175V: 373.Google Scholar
  54. Kiessling, R., Klein, E., and Wigzell, H., 1975, Natural killer cells in the mouse, tumor cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype, Eur. J. Immunol. 5: 112.PubMedCrossRefGoogle Scholar
  55. Kiselow, P., Hurst, J. A., Shiku, H., Beverley, P. C. L., Hoffman, M. K., Boyse, E. A., and Oettegen, H. F., 1975, Ly antigens as markers for functionally distinct subpopulations of thymus derived lymphocytes of the mouse, Nature (London) 253: 219.CrossRefGoogle Scholar
  56. Klein, G., and Klein, E., 1975, Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens modified forms of H-2 or linked determinants? Int. J. Cancer 15: 879.PubMedCrossRefGoogle Scholar
  57. Kölsch, E., 1975, The genetic control of T cell-mediated immunity against the DBA/2 mastocytoma P815. II. Low responsiveness in T cell-mediated cytotoxicity accompanied by the inability to produce antibodies in a secondary response, Eur. J. Immunol. 5: 527.PubMedCrossRefGoogle Scholar
  58. Kripke, M. L., 1974, Antigenicity of murine skin tumors induced by ultraviolet light, J. Natl. Cancer Inst. 53: 1333.PubMedGoogle Scholar
  59. Kripke, M. L., and Fisher, M. S., 1976, Immunologic parameters of ultraviolet carcinogenesis, J. Natl. Cancer Inst. 57: 211.PubMedGoogle Scholar
  60. Lilly, F., 1972, Mouse leukemia: A model of a multiple-gene disease, J. Natl. Cancer Inst. 49 (4): 927.PubMedGoogle Scholar
  61. Meruello, D., Deak, B., and McDevitt, H. O., 1977, Genetic control of cell mediated responsiveness to an AKR tumor associated antigen: Mapping of the locus involved to the I region of the H-2 complex, J. Exp. Med. 146: 1367.CrossRefGoogle Scholar
  62. Meruello, D., Smith, D., Flieger, N., and McDevitt, H. O., 1979, H-2 linked resistance to spontaneous AKR leukemia. J. Supramol. Struct. Suppl. 3: 320.Google Scholar
  63. Mikulska, Z. B., Smith, C., and Alexander, P., 1966, Evidence for an immunological reaction of the host directed against its own actively growing primary tumor, J. Natl. Cancer Inst. 36: 29.PubMedGoogle Scholar
  64. Miller, J. F. A. P., Brunner, K. T., Sprent, J., Russellard, P. J., and Mitchell, G. F., 1971, Thymus-derived cells as killer cells in cell mediated immunity, Transplant. Proc. HI(I): 915.Google Scholar
  65. Muhlböck, O., and Dux, A., 1971, Histocompatibility genes and susceptibility to mammary tumor virus in mice, Transplant. Proc. HI: 1247.Google Scholar
  66. Murphy, D. B., Herzenberg, L. A., Okumura, K., Herzenberg, L. A., and McDevitt, H. O., 1976, A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes, J. Exp. Med. 144: 699.PubMedCrossRefGoogle Scholar
  67. Nelson, D. L., Sachs, D. H., and Dickler, H. B., 1977, Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens, J. Immunol. 119: 1034.PubMedGoogle Scholar
  68. Old, L. J., Clarke, D. A., Benacerraf, B., and Stockert, D., 1962, Effect of prior splenectomy on the growth of sarcoma 180 in normal and bacillus Calmette-Guerin infected mice, Expérientia 18: 335.PubMedCrossRefGoogle Scholar
  69. Oth, D., Robert, F., Berebbi, M., and Meyer, G., 1976, Decreased resistance in some hetero-zygotes in H- 2-linked immune response to polyoma-induced tumour, Nature (London) 259: 316.CrossRefGoogle Scholar
  70. Perry, L. L., Benacerraf, B., McCluskey, R., and Greene, M. I., 1978a, Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantisera, Am. J. Pathol. 92: 491.PubMedGoogle Scholar
  71. Perry, L. L., Benacerraf, B, and Greene, M. I., 1978b, Tumor antigen specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo, J. Immunol. 121: 2144.PubMedGoogle Scholar
  72. Perry, L. L., Dorf, M. E., Benacerraf, B., and Greene, M. I., 1979, Regulation of immune response to tumor antigen: Interference with syngeneic tumor immuntiy by anti-I-A alloantisera, Proc. Natl. Acad. Sci. U.S.A. 76: 920.PubMedCrossRefGoogle Scholar
  73. Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18 (6): 769.PubMedGoogle Scholar
  74. Reinherz, E. L., Strekelkaus, A. J., O’Brien, C., and Schlossman, S. F., 1979, Phenotypic and functional distinctions between the TH2 and JRA+ T cell subsets in mice, J. Immunol. 123: 83.PubMedGoogle Scholar
  75. Reinisch, C. L., Andrew, S. L., and Schlossman, S. F., 1977, Suppressor cell regulation of tumor immunity: Abrogation by adult thymectomy, Proc. Natl. Acad. Sci. U.S.A. 74 (7): 2989.PubMedCrossRefGoogle Scholar
  76. Rohrer, J. W., Odermatt, B., and Lynch, R. G., 1979, Immune regulation of murine myeloma, J. Immunol. 122: 2011.Google Scholar
  77. Röllinghoff, M., and Wagner, H., 1973, In vitro induction of tumor specific immunity: Requirements for T lymphocytes and tumor growth inhibition in vivo, Eur. J. Immunol. 3: 471.Google Scholar
  78. Rosenthal, A. A., and Shevach, E. M., 1973, Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes, J. Exp. Med. 138: 1194.PubMedCrossRefGoogle Scholar
  79. Rotter, V., and Trainin, N., 1975, Inhibition of tumor growth in syngeneic chimeric mice mediated by a depletion of suppressor T cells, Transplantation 20 (1): 68.PubMedCrossRefGoogle Scholar
  80. Rouse, B. T., Röllinghoff, M., and Warner, N. L., 1972, Anti-C) serum-induced suppression of the cellular transfer of tumour-specific immunity to a syngeneic plasma cell tumour, Nature (London) New Biology 238: 116.Google Scholar
  81. Sakano, H., Hüppi, K., Heinrich, G., and Tonegawa, S., 1979, Sequences at the somatic recombination sites of immunoglobulin light-chain genes, Nature (London) 280: 288.CrossRefGoogle Scholar
  82. Schrader, J. W., and Edelman, G. M., 1976, Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells, J. Exp. Med. 143: 601.PubMedCrossRefGoogle Scholar
  83. Schwartz, R. H., Vano, A., Stimplfing, J. H., and Paul, W. E., 1979, Gene complementation in the T-lymphocyte proliferative response to poly(Glu Lys Phe)n. A demonstration that both immune response gene products must be expressed in the same antigen presenting cell, J. Exp. Med. 149: 40.PubMedCrossRefGoogle Scholar
  84. Seidman, G. J., Max, E. E., and Leder, P., 1979, A K immunoglobulin gene is formed by site-specific recombination without further somatic mutation, Nature (London) 280: 370.CrossRefGoogle Scholar
  85. Shearer, G. M., 1974, Cell mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes, Eur. J. Immunol. 4: 527.PubMedCrossRefGoogle Scholar
  86. Shiku, H., Takahashi, T., Beam, M. A., Old, L. J., and Oettgen, H. F., 1976, Ly phenotype of cytotoxic T cells for syngeneic tumor, J. Exp. Med. 144: 1116.PubMedCrossRefGoogle Scholar
  87. Shimuzu, K., and Shen, R. W., 1979, Role of different T cell sets in the rejection of syngeneic chemically induced tumors, J. Immunol 122: 1162.Google Scholar
  88. Shin, H. S., Hayden, M., Langesy, S., Kaliss, N., and Smith, M. R., 1975, Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts, J. Immunol. 114: 1255.PubMedGoogle Scholar
  89. Small, M., and Trainin, N., 1976, Separation of populations of sensitized lymphoid cells into fractions inhibiting and fractions enhancing syngeneic tumor growth in vivo, J. Immunol. 117 (1): 292.PubMedGoogle Scholar
  90. Spellman, C. W., and Daynes, R. A., 1978, Ultraviolet light induced murine suppressor lymphocytes dictate specificity of anti ultraviolet light tumor immune responses, Cell. Immunol. 38: 25.PubMedCrossRefGoogle Scholar
  91. Spiegelberg, H. L., Perlmann, H., and Perlmann, P., 1976, Interaction of K lymphocytes with myeloma proteins of different IgG subclasses, J. Immunol 116: 1464.Google Scholar
  92. Stutman, O., Shen, F. W., and Boyse, E. A., 1977, Ly phenotype of T cells cytotoxic for syngeneic mouse mammary tumors: Evidence for T cell interactions, Proc. Natl. Acad. Sci. U.S.A. 74 (12): 5667.PubMedCrossRefGoogle Scholar
  93. Tada, T., Taniguchi, M., and David, C. S., 1976, Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion. Assignment of the gene(s) that codes for the suppressive T- cell factor in the H-2 histocompatibility complex, J. Exp. Med. 144: 713.PubMedCrossRefGoogle Scholar
  94. Tada, T., Takemori, T., Okumura, K., Nonaka, M., and Tokubishi, T., 1978, Two distinct types of helper T cells involved in the secondary antibody response independent and synergistic effects of Ia-and la* helper T cells, J. Exp. Med. 147 (2): 444.CrossRefGoogle Scholar
  95. Takei, P., Levy, J. G., and Kilburn, D. G., 1976, In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice, J. Immunol. 116: 288.PubMedGoogle Scholar
  96. Thomas, D. W., and Shevach, E. W., 1977, Nature of the antigenic complex recognized by T lymphocytes: Specific sensitization by antigens associated with allogeneic macrophages, Proc. Natl. Acad. ScL U.S.A. 74: 2104.CrossRefGoogle Scholar
  97. Treves, A. J., Schecter, B., Cohen, I. R., and Feldmann, M., 1976, Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens, J. Immunol 116: 1059.PubMedGoogle Scholar
  98. Umiel, T., and Trainin, N., 1974, Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes, Transplantation 18 (3): 244.PubMedCrossRefGoogle Scholar
  99. Vadas, M. A., Miller, J. F. A. P., Whitelaw, A. M., and Gamble, J. R., 1977, Regulation by the H-2 gene complex of delayed type hypersensitivity, Immunogenetics 4: 137.CrossRefGoogle Scholar
  100. Waldmann, T. A., Broder, S., Blaese, R. M., Dunn, M., Blackman, M., and Strober, W., 1974, Role of suppressor T cells in pathogenesis of common variable hypogamma-globulinemia, Lancet 2: 609.PubMedCrossRefGoogle Scholar
  101. Waltenbaugh, C. J., Theze, J., Kapp, J. A., and Benacerraf, B., 1977, Immunosuppressive factor(s) specific for L-glutamic acids-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells, J. Exp. Med. 146: 970.PubMedCrossRefGoogle Scholar
  102. Warner, N. L., 1975, Autoimmunity and the pathogenesis of plasma cell tumor induction in NZB inbred and hybrid mice, Immunogenetics 2: 1.CrossRefGoogle Scholar
  103. Whitmore, A. C., and Haughton, G., 1975, Genetic control of susceptibility of mice to rous sarcoma virus tumorigenesis. I. Tumor incidence in inbred strains and Ft hybrids, Immunogenetics 2: 379.CrossRefGoogle Scholar
  104. Williams, R., Dorf, M. E., and Benacerraf, B., 1975, H-2-linked genetic control of resistance to histocompatible tumors, Cancer Res. 35: 1586.PubMedGoogle Scholar
  105. Winn, H. J., 1961, Immune mechanisms in homotransplantation. II. Quantitative assay of the immunological activity in lymphoid cells stimulated by tumor homografts, J. Immunol. 86: 228.PubMedGoogle Scholar
  106. Yu, A., Watts, H., Jaffe, N., and Parkmor, R., 1977, Both inhibitor and cytotoxic lymphocytes in patients with osteogenic sarcoma, New Eng. J. Med. 297 (3): 121.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1980

Authors and Affiliations

  • Mark Irwin Greene
    • 1
  1. 1.Department of PathologyHarvard Medical SchoolBostonUSA

Personalised recommendations